ROHYPNOL

This brand name is authorized in Austria, Brazil, Germany, Hong Kong SAR China, Nigeria.

Active ingredients

The drug ROHYPNOL contains one active pharmaceutical ingredient (API):

1	Flunitrazepam UNII 620X0222FQ - FLUNITRAZEPAM
	Flunitrazepam is a member of the benzodiazepine group of drugs and is closely related to nitrazepam, flurazepam and clonazepam. It has marked sedative and hypnotic properties with a rapid onset of action and is used in severe cases of insomnia.
	Read more about Flunitrazepam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CD03	Flunitrazepam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509018020021818, 509018020021918, 529205401112314, 529205402119312
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	04846395
HK	Department of Health Drug Office	12370
NG	Registered Drug Product Database	04-0150
Switch country to Nigeria in order to find specific presentations of ROHYPNOL